meizitang is becoming a serious health problem

After the United States acquired the promotion of the products in the world was a great success in Europe 3 U.S. market accounted for 30% to 50% of the market share of the weight loss drugs, 50% market share in Hong Kong, Taiwan 70 percent in China in 2001, but suffered a crisis in Italy recall events, as well as domestic generic violations such as mass advertising of the drug manufacturers a series of the Gui adverse events have had to stop selling the drug business in urgent need of a new growth point, the company decided, such as some areas in mainland China in 2007. meizitang is becoming a serious health problem.

The incidence of significant changes with gender, age, socio-economic status and ethnicity. women was 35%, 31% in men and between 20-55 years of age the incidence of more than 2 times. Among women, obesity and socio-economic situation is extremely relevant, lower socio-economic status of women is often higher socio-economic status of women, although the prevalence among black and white men there was no significant difference, but Obesity in black women than white women in general, the incidence of 33% compared with white women, it affects 60% of middle-aged black women. obesity has now become a global epidemic in Europe.

In Shanghai, Jiangsu, Zhejiang and other places the re-launch the product, whether to proceed with a national promotion and the sales situation, the original intention of this project. 1.3 the concept of obesity and its hazards of obesity is a chronic disease of the excessive accumulation of fat in a physical as well as a threat to health, the World Health Organization (WHO ) was officially announced that obesity is a disease of high prevalence of obesity in the United States, and rising over the past 10 years, the total incidence rate increased from 25% to 33%, an increase of 1/3 in 1999. It engenders a great potential meizitang treatment market.